| Miss Rebecca Rene' Boust, CRNA | |
|
800 Ravenhill Dr, Atchison, KS 66002-9204 | |
| (913) 367-5360 | |
| (913) 674-2013 |
| Full Name | Miss Rebecca Rene' Boust |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 13 Years |
| Location | 800 Ravenhill Dr, Atchison, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043591001 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | AP60246708 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kansas Hospital | Kansas city, KS | Hospital |
| Stormont Vail Hospital | Topeka, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Associates Of Topeka Pa | 5698675437 | 54 |
| Kansas University Physicians, Inc. | 8921911587 | 1456 |
News Archive
Executives from Senexis Limited (Cambridge,UK) signed an agreement with O2h (Ahmedabad, India) under which O2h will provide Senexis with chemistry services to support a patent filing on a novel chemical series that have shown potential in pre-clinical models, as disease modifying treatments for Alzheimer's Disease.
The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with pleural mesothelioma, a rare and deadly form of cancer that arises in the outer lining of the lungs and internal chest wall, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania.
America's seniors suffer a disproportionate burden of oral disease while having fewer resources for appropriate care - and these issues will be exacerbated as the elderly population grows.
Disruption of proteins expressed at the junctures between cells (known as tight junctions) is a hallmark of cancer cell invasion and spread (metastasis).
› Verified 7 days ago
| Entity Name | Anesthesia Associates Of Topeka Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518933837 PECOS PAC ID: 5698675437 Enrollment ID: O20040109000467 |
News Archive
Executives from Senexis Limited (Cambridge,UK) signed an agreement with O2h (Ahmedabad, India) under which O2h will provide Senexis with chemistry services to support a patent filing on a novel chemical series that have shown potential in pre-clinical models, as disease modifying treatments for Alzheimer's Disease.
The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with pleural mesothelioma, a rare and deadly form of cancer that arises in the outer lining of the lungs and internal chest wall, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania.
America's seniors suffer a disproportionate burden of oral disease while having fewer resources for appropriate care - and these issues will be exacerbated as the elderly population grows.
Disruption of proteins expressed at the junctures between cells (known as tight junctions) is a hallmark of cancer cell invasion and spread (metastasis).
› Verified 7 days ago
| Entity Name | Amberwell Atchison Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932151487 PECOS PAC ID: 2466363858 Enrollment ID: O20040329001560 |
News Archive
Executives from Senexis Limited (Cambridge,UK) signed an agreement with O2h (Ahmedabad, India) under which O2h will provide Senexis with chemistry services to support a patent filing on a novel chemical series that have shown potential in pre-clinical models, as disease modifying treatments for Alzheimer's Disease.
The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with pleural mesothelioma, a rare and deadly form of cancer that arises in the outer lining of the lungs and internal chest wall, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania.
America's seniors suffer a disproportionate burden of oral disease while having fewer resources for appropriate care - and these issues will be exacerbated as the elderly population grows.
Disruption of proteins expressed at the junctures between cells (known as tight junctions) is a hallmark of cancer cell invasion and spread (metastasis).
› Verified 7 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
Executives from Senexis Limited (Cambridge,UK) signed an agreement with O2h (Ahmedabad, India) under which O2h will provide Senexis with chemistry services to support a patent filing on a novel chemical series that have shown potential in pre-clinical models, as disease modifying treatments for Alzheimer's Disease.
The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with pleural mesothelioma, a rare and deadly form of cancer that arises in the outer lining of the lungs and internal chest wall, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania.
America's seniors suffer a disproportionate burden of oral disease while having fewer resources for appropriate care - and these issues will be exacerbated as the elderly population grows.
Disruption of proteins expressed at the junctures between cells (known as tight junctions) is a hallmark of cancer cell invasion and spread (metastasis).
› Verified 7 days ago
| Entity Name | Anesthesia Associates Of Kansas City Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174504732 PECOS PAC ID: 1951206168 Enrollment ID: O20050721001069 |
News Archive
Executives from Senexis Limited (Cambridge,UK) signed an agreement with O2h (Ahmedabad, India) under which O2h will provide Senexis with chemistry services to support a patent filing on a novel chemical series that have shown potential in pre-clinical models, as disease modifying treatments for Alzheimer's Disease.
The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with pleural mesothelioma, a rare and deadly form of cancer that arises in the outer lining of the lungs and internal chest wall, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania.
America's seniors suffer a disproportionate burden of oral disease while having fewer resources for appropriate care - and these issues will be exacerbated as the elderly population grows.
Disruption of proteins expressed at the junctures between cells (known as tight junctions) is a hallmark of cancer cell invasion and spread (metastasis).
› Verified 7 days ago
| Entity Name | Novamed Eye Surgery Center Of Overland Park Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629078043 PECOS PAC ID: 7012909872 Enrollment ID: O20051109001232 |
News Archive
Executives from Senexis Limited (Cambridge,UK) signed an agreement with O2h (Ahmedabad, India) under which O2h will provide Senexis with chemistry services to support a patent filing on a novel chemical series that have shown potential in pre-clinical models, as disease modifying treatments for Alzheimer's Disease.
The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with pleural mesothelioma, a rare and deadly form of cancer that arises in the outer lining of the lungs and internal chest wall, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania.
America's seniors suffer a disproportionate burden of oral disease while having fewer resources for appropriate care - and these issues will be exacerbated as the elderly population grows.
Disruption of proteins expressed at the junctures between cells (known as tight junctions) is a hallmark of cancer cell invasion and spread (metastasis).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Rebecca Rene' Boust, CRNA 810 Ravenhill Dr, Atchison, KS 66002-9204 Ph: (913) 367-5360 | Miss Rebecca Rene' Boust, CRNA 800 Ravenhill Dr, Atchison, KS 66002-9204 Ph: (913) 367-5360 |
News Archive
Executives from Senexis Limited (Cambridge,UK) signed an agreement with O2h (Ahmedabad, India) under which O2h will provide Senexis with chemistry services to support a patent filing on a novel chemical series that have shown potential in pre-clinical models, as disease modifying treatments for Alzheimer's Disease.
The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with pleural mesothelioma, a rare and deadly form of cancer that arises in the outer lining of the lungs and internal chest wall, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania.
America's seniors suffer a disproportionate burden of oral disease while having fewer resources for appropriate care - and these issues will be exacerbated as the elderly population grows.
Disruption of proteins expressed at the junctures between cells (known as tight junctions) is a hallmark of cancer cell invasion and spread (metastasis).
› Verified 7 days ago
Cari Meats, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 800 Ravenhill Dr, Atchison, KS 66002 Phone: 913-367-2131 | |
Lane Tyler Young, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 800 Ravenhill Dr, Atchison, KS 66002 Phone: 913-367-2131 | |
Andrew Durbin, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 800 Ravenhill Dr, Atchison, KS 66002 Phone: 913-367-2131 | |
Charlie K. Wilson Jr., CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 800 Raven Hill Drive, Atchison, KS 66002 Phone: 913-367-2131 Fax: 913-674-2023 |